The largest genetic study to date of Alzheimer’s Disease in African Americans reveals hundreds of distinct gene expression ...

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

Alzheimer's Disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Texas voters approved a $3 billion amendment to advance brain health research on Nov. 4, establishing the Dementia Prevention and Research Institute of Texas under Texas Proposition 14.  The measure’s ...

Our Top PicksBest rechargeableJabra EnhanceBest basic optionsMDHearingMost discreetEargoThe combination of hearing loss and dementia presents a unique challenge for family members and caregivers ...

One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they ...

The lights of the iconic Route 66 Drive-Thru Shield in downtown Kingman shined brightly in teal during the week of Nov. 3 to ...

With evidence of daily oscillations in brain cells affected by neurodegeneration, researchers can investigate ways to counter ...

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease ...

WPBF 25 goes "On the Record" on Alzheimer's Disease and how medical professionals are working to combat the disease.

New research has found that the loss of social memory – recognizing friends and family – in Alzheimer's disease (AD) could ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...